143 related articles for article (PubMed ID: 8548759)
21. Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers.
Wilczynski SP; Chen YY; Chen W; Howell SB; Shively JE; Alberts DS
Hum Pathol; 2005 Mar; 36(3):242-9. PubMed ID: 15791568
[TBL] [Abstract][Full Text] [Related]
22. Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival.
Eoli M; Menghi F; Bruzzone MG; De Simone T; Valletta L; Pollo B; Bissola L; Silvani A; Bianchessi D; D'Incerti L; Filippini G; Broggi G; Boiardi A; Finocchiaro G
Clin Cancer Res; 2007 May; 13(9):2606-13. PubMed ID: 17473190
[TBL] [Abstract][Full Text] [Related]
23. Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas.
Puputti M; Tynninen O; Sihto H; Blom T; Mäenpää H; Isola J; Paetau A; Joensuu H; Nupponen NN
Mol Cancer Res; 2006 Dec; 4(12):927-34. PubMed ID: 17189383
[TBL] [Abstract][Full Text] [Related]
24. PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of the gastrointestinal tract.
Rossi G; Valli R; Bertolini F; Marchioni A; Cavazza A; Mucciarini C; Migaldi M; Federico M; Trentini GP; Sgambato A
Histopathology; 2005 May; 46(5):522-31. PubMed ID: 15842634
[TBL] [Abstract][Full Text] [Related]
25. Molecular analysis of the EGFR gene in astrocytic gliomas: mRNA expression, quantitative-PCR analysis of non-homogeneous gene amplification and DNA sequence alterations.
Arjona D; Bello MJ; Alonso ME; Aminoso C; Isla A; De Campos JM; Sarasa JL; Gutierrez M; Villalobo A; Rey JA
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):384-94. PubMed ID: 16008822
[TBL] [Abstract][Full Text] [Related]
26. Loss of heterozygosity at 11p15 in malignant glioma.
Sonoda Y; Iizuka M; Yasuda J; Makino R; Ono T; Kayama T; Yoshimoto T; Sekiya T
Cancer Res; 1995 May; 55(10):2166-8. PubMed ID: 7743518
[TBL] [Abstract][Full Text] [Related]
27. Platelet-derived growth factor receptor is expressed by cells in the early oligodendrocyte lineage.
Ellison JA; de Vellis J
J Neurosci Res; 1994 Jan; 37(1):116-28. PubMed ID: 8145299
[TBL] [Abstract][Full Text] [Related]
28. Comparative molecular genetic profiles of anaplastic astrocytomas/glioblastomas multiforme and their subsequent recurrences.
Saxena A; Shriml LM; Dean M; Ali IU
Oncogene; 1999 Feb; 18(6):1385-90. PubMed ID: 10022821
[TBL] [Abstract][Full Text] [Related]
29. Identification of MG-160, a FGF binding medial Golgi sialoglycoprotein, in brain tumors: an index of malignancy in astrocytomas.
Yamaguchi F; Morrison RS; Gonatas NK; Takahashi H; Sugisaki Y; Teramoto A
Int J Oncol; 2003 May; 22(5):1045-9. PubMed ID: 12684670
[TBL] [Abstract][Full Text] [Related]
30. Expression of tissue factor correlates with grade of malignancy in human glioma.
Hamada K; Kuratsu J; Saitoh Y; Takeshima H; Nishi T; Ushio Y
Cancer; 1996 May; 77(9):1877-83. PubMed ID: 8646688
[TBL] [Abstract][Full Text] [Related]
31. Localization of aberrant messenger RNA of epidermal growth factor receptor (EGFR) in malignant glioma.
Tsugu A; Kijima H; Yamazaki H; Ohnishi Y; Takamiya Y; Abe Y; Ueyama Y; Sato O; Tamaoki N; Nakamura M
Anticancer Res; 1997; 17(3C):2225-32. PubMed ID: 9216693
[TBL] [Abstract][Full Text] [Related]
32. Gliomas.
Collins VP
Cancer Surv; 1998; 32():37-51. PubMed ID: 10489622
[TBL] [Abstract][Full Text] [Related]
33. Expression of KIT and PDGFR is associated with a good prognosis in neuroblastoma.
Shimada A; Hirato J; Kuroiwa M; Kikuchi A; Hanada R; Wakai K; Hayashi Y
Pediatr Blood Cancer; 2008 Feb; 50(2):213-7. PubMed ID: 17941064
[TBL] [Abstract][Full Text] [Related]
34. PDGF-C and -D and their receptors PDGFR-alpha and PDGFR-beta in atherosclerotic human arteries.
Karvinen H; Rutanen J; Leppänen O; Lach R; Levonen AL; Eriksson U; Ylä-Herttuala S
Eur J Clin Invest; 2009 Apr; 39(4):320-7. PubMed ID: 19292888
[TBL] [Abstract][Full Text] [Related]
35. Expression of c-kit and platelet-derived growth factor receptors in ovarian granulosa cell tumors.
Rocconi RP; Matthews KS; Kimball KJ; Conner MG; Baker AC; Barnes MN
Reprod Sci; 2008 Sep; 15(7):673-7. PubMed ID: 18492696
[TBL] [Abstract][Full Text] [Related]
36. Clonal genomic alterations in glioma malignancy stages.
James CD; Carlbom E; Dumanski JP; Hansen M; Nordenskjold M; Collins VP; Cavenee WK
Cancer Res; 1988 Oct; 48(19):5546-51. PubMed ID: 2901288
[TBL] [Abstract][Full Text] [Related]
37. Platelet-derived growth factor in human glioma.
Westermark B; Heldin CH; Nistér M
Glia; 1995 Nov; 15(3):257-63. PubMed ID: 8586462
[TBL] [Abstract][Full Text] [Related]
38. A human brain tumor-derived PDGFR-alpha deletion mutant is transforming.
Clarke ID; Dirks PB
Oncogene; 2003 Feb; 22(5):722-33. PubMed ID: 12569364
[TBL] [Abstract][Full Text] [Related]
39. [Expression of fibroblast growth factor receptors (FGFRs) mRNA in human astrocytomas].
Yamada SM; Bruner JM; Berger MS; Morrison RS
No To Shinkei; 1996 Apr; 48(4):363-70. PubMed ID: 8679334
[TBL] [Abstract][Full Text] [Related]
40. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
